Skip to main content
MarketStoryBook

Teva Pharmaceutical Industries in 1 story

The narratives TEVA currently appears in, with its side and exposure in each.

Bull side

1 story
  • America Imports the World's Drug Prices

    TEVA in “America Imports the World's Drug Prices”

    Not enough historyExposure: not rated yet

    US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.

    Teva benefits when payers accelerate substitution toward generic and biosimilar therapies.

Bear side

0 stories

No bear-side stories for TEVA yet.